Development and Preclinical Characterization of an Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity Against Myeloid Leukemia

被引：2
|
作者：
Koerner, Samuel [1 ]
Leibold, Julia [1 ]
Grosse-Hovest, Ludger [2 ]
Buehring, Hans-Joerg [1 ]
Jung, Gundram [1 ]
Kanz, Lothar [3 ]
Salih, Helmut R. [1 ,4 ,5 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] SYNIMMUNE GmbH, Tubingen, Germany
[3] Univ Hosp Tuebingen, Tubingen, Germany
[4] German Canc Consortium DKTK, Heidelberg, Germany
[5] German Canc Res Ctr, Heidelberg, Germany
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.2309.2309
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Generation, Functional Characterization and Clinical Application of a Novel Fc-Optimized Anti-FLT3 Antibody for the Treatment of Acute Myeloid Leukemia
    Salih, Helmut R.
    Baessler, Tina
    Hofmann, Martin
    Grosse-Hovest, Ludger
    Bamberg, Maximilian
    Aulwurm, Steffen
    Buehring, Hans-Joerg
    Kanz, Lothar
    Jung, Gundram
    BLOOD, 2010, 116 (21) : 902 - 903
  • [22] Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
    van Elsas, Marit J.
    van der Schoot, Johan M. S.
    Bartels, Alexander
    Steuten, Kas
    van Dalen, Duco
    Wijfjes, Zacharias
    Figdor, Carl G.
    van Hall, Thorbald
    van der Burg, Sjoerd H.
    Verdoes, Martijn
    Scheeren, Ferenc A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [23] An Fc-optimized CD19 antibody as treatment option for lymphoid B-cell malignancies
    Seidel, U. J.
    Grosse-Hovest, L.
    Schlegel, P.
    Hofmann, M.
    Vogt, F.
    Schuster, F. R.
    Meisel, R.
    Witte, K.
    Aulwurm, S.
    Pyz, E.
    Rammensee, H.
    Jung, G.
    Handgretinger, R.
    Lang, P.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E25 - E25
  • [24] A Novel Fc-Optimized Antibody Drug Conjugate Targeting CD7 is Active in Preclinical Models of T-ALL
    Gehlert, C. L.
    Schewe, D. M.
    Klausz, K.
    Schrappe, M.
    Cario, G.
    Baldus, C. D.
    Gramatzki, M.
    Lenk, L.
    Kellner, C.
    Peipp, M.
    KLINISCHE PADIATRIE, 2024, 236 (03): : 205 - 205
  • [25] Bimodal Induction of NK Cell Reactivity Against Acute Myeloid (AML) and Chronic Lymphoid Leukemia (CLL) by Fc-Engineered GITR-Fc Fusion Proteins.
    Steinbacher, Julia
    Schmiedel, Benjamin J.
    Werner, Antje
    Nuebling, Tina
    Buechele, Corina
    Grosse-Hovest, Ludger
    Kanz, Lothar
    Salih, Helmut R.
    BLOOD, 2012, 120 (21)
  • [26] A Novel Fc-Optimized Antibody Drug Conjugate Targeting CD7 As a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia
    Gehlert, Carina Lynn
    Schewe, Denis Martin
    Klausz, Katja
    Krohn, Steffen
    Winterberg, Dorothee
    Vogiatzi, Fotini
    Boje, Ammelie Svea
    Lux, Anja
    Nimmerjahn, Falk
    Scherliess, Regina
    Humpe, Andreas
    Schrappe, Martin
    Cario, Gunnar
    Valerius, Thomas
    Fransecky, Lars
    Brueggemann, Monika
    Baldus, Claudia D.
    Gramatzki, Martin
    Lenk, Lennart
    Kellner, Christian
    Peipp, Matthias
    BLOOD, 2023, 142
  • [27] A first in man study with a Fc-optimized FLT3 antibody for treatment of acute myeloid leukemia with minimal residual disease
    Doerfel, D.
    Doehner, K.
    Kapp-Schwoerer, S.
    Kayser, S.
    Thol, F.
    Heuser, M.
    Grosse-Hovest, L.
    Kanz, L.
    Schlenk, R. F.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 8 - 8
  • [28] Generation and preclinical evaluation of Fc-optimized RANK-Ig fusion proteins for neutralization of soluble RANKL and targeting of Myeloma and CLL cells for NK reactivity
    Scheible, C.
    Schmiedel, B. J.
    Baessler, T.
    Wende, C. M.
    Wirths, S.
    Azuma, M.
    Schneider, P.
    Grosse-Hovest, L.
    Kanz, L.
    Salih, H. R.
    ONKOLOGIE, 2010, 33 : 282 - 282
  • [29] An Fc-optimized monoclonal antibody against CD32B, the human inhibitory Fc-γreceptor IIB, in the immunotherapy of B-cell malignanacy.
    Stavenhagen, Jeffrey B.
    Gorlatov, Sergey
    Tuaillon, Nadine
    Rankin, Christopher T.
    Veri, Maria-Concetta
    Inzunza, David
    Burke, Stephen
    Huang, Ling
    Li, Hua
    Thomas, Shannon
    Johnson, Syd
    Ravetch, Jeffrey
    Koenig, Scott
    Bonvini, Ezio
    BLOOD, 2006, 108 (11) : 715A - 715A
  • [30] Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody
    Seidel, Ursula Joerdis Eva
    Grosse-Hovest, Ludger
    Schlegel, Patrick
    Hofmann, Martin
    Schuster, Friedhelm R.
    Meisel, Roland
    Witte, Kai-Erik
    Aulwurm, Steffen
    Pyz, Elwira
    Rammensee, Hans-Georg
    Jung, Gundram
    Handgretinger, Rupert
    Lang, Peter
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
12345